Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Closed Pre-Solicitation Posted
- Solicitation number
- BARDA-CBRN-10302024
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) is issuing a Sources Sought Notice (SSN) to collect feedback from current and prospective vaccine development partners for Marburg virus (MARV) and Sudan virus (SUDV) vaccines. BARDA is seeking information on individual monovalent vaccines targeting MARV and SUDV that are currently in Phase 2 clinical trials or beyond. Respondents are asked to provide details on the vaccine candidate, clinical development status, nonclinical studies, and manufacturing. Responses are due by November 18, 2024 and should be limited to 10 pages total. This SSN is for information gathering purposes only and does not obligate the government to award a contract.
There is no set-aside designation for this opportunity. The government has not identified any potential incumbents or current contractors. The purpose of this SSN is to strengthen BARDA's understanding of the current and future marketplace for MARV and SUDV vaccines, and any resulting solicitation will be posted on SAM.gov, but responses to this SSN will not be considered adequate responses to a solicitation.
Notice text
The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), is issuing this Sources Sought Notice (SSN) to collect feedback from current and prospective MARV and SUDV vaccine development partners. Information from this SSN will serve as continued market research for possible future acquisitions and programs. The information collected in response to this SSN is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.
Files
| File | Type | Posted |
|---|---|---|
| SSN MARV SUDV Vaccines.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity